Biological
R21 clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2019
Studies by the year they started
3 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2019 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 3
Often tested with
Tested in the same studies.
Vaccines, Combined (1) · Measles Vaccine (1) · Rubella Vaccine (1) · Yellow Fever Vaccine (1) · Typhoid-Paratyphoid Vaccines (1)
Studies
Open first, then newest update. How each study uses R21 is read from its arms, and is right about nine times in ten.
Testing it · 3
- Infant Malaria Vaccine Schedule OptimizationActive, not recruitingPhase 2PATHNCT06879327Written as R21 Matrix-M (R21/MM) Malaria Vaccine
- A Study to Determine if a New Malaria Vaccine is Safe and Induces Immunity Among Kenyan Adults, Young Children and InfantsCompletedPhase 1/2University of OxfordNCT03580824Written as R21 in Matrix- M adjuvant vaccine
- VAC 072-An Efficacy Study of R21/MM in Different Dose SchedulesCompletedPhase 1/2University of OxfordNCT03970993Written as R21 Matrix-M vaccination